Parathyroid hormone (1-34) (rat) acetate|西域试剂

Parathyroid hormone (1-34) (rat) acetate,98.14%

产品编号：Bellancom-P2279A| 分子式：C₁₈₂H₂₉₅N₅₅O₅₀S₂| 分子量：4117.76

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用，

货号	价格	库存与货期
Bellancom-P2279A	￥3200.00	杭州北京（现货）
Bellancom-P2279A	￥9000.00	杭州北京（现货）
Bellancom-P2279A	￥14500.00	杭州北京（现货）

增值税发票√顺丰快递√订货电话：18601927057

Parathyroid hormone (1-34) (rat) acetate

产品介绍

Parathyroid hormone (1-34) (rat) (acetate) 是甲状旁腺激素。Parathyroid hormone (1-34) (rat) 可改善皮质和松质骨结构。Parathyroid hormone (1-34) (rat) 可用于骨质疏松症的研究。

生物活性

Parathyroid hormone (1-34) (rat) (acetate) is a parathyroid hormone. Parathyroid hormone (1-34) (rat) improves both cortical and cancellous bone structure. Parathyroid hormone (1-34) (rat) can be used for the research of osteoporosis.

体外研究

体内研究

Parathyroid hormone (1-34) (rat) (acetate) (s.c; 40 mg/kg; per day; for 4 weeks) promotes the formation of bone.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	ovariectomized (Ovx) rats
Dosage:	40 mg/kg
Administration:	s.c, per day, for 4 weeks
Result:	Preserved Cn-BV/TV and trabecular connectivity, and combined estrogen and PTH caused a 40% increment in Cn-BV/TV while maintaining comparable trabecular connectivity with that seen in the Shamoperated animals. Prevented further loss of connectivity and Cn-BV/TV, and combined estrogen and PTH resulted in as much as a 300% improvement in one of the parameters of trabecular connectivity, node to node strut length, and a 106% increase in Cn-BV/TV, with respect to the bone status at the initiation of treatment.

体内研究

Parathyroid hormone (1-34) (rat) (acetate) (s.c; 40 mg/kg; per day; for 4 weeks) promotes the formation of bone.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	ovariectomized (Ovx) rats
Dosage:	40 mg/kg
Administration:	s.c, per day, for 4 weeks
Result:	Preserved Cn-BV/TV and trabecular connectivity, and combined estrogen and PTH caused a 40% increment in Cn-BV/TV while maintaining comparable trabecular connectivity with that seen in the Shamoperated animals. Prevented further loss of connectivity and Cn-BV/TV, and combined estrogen and PTH resulted in as much as a 300% improvement in one of the parameters of trabecular connectivity, node to node strut length, and a 106% increase in Cn-BV/TV, with respect to the bone status at the initiation of treatment.

性状

Solid

溶解性数据

In Vitro:

H₂O : ≥ 100 mg/mL (24.29 mM)

* "≥" means soluble, but saturation unknown.

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	0.2429 mL	1.2143 mL	2.4285 mL
5 mM	0.0486 mL	0.2429 mL	0.4857 mL
10 mM	0.0243 mL	0.1214 mL	0.2429 mL

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen)。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Sealed storage, away from moisture and light, under nitrogen